Evidence map›Paper›PMID 19917317›Full record

ArticleJournal of virological methods2010

Identification of the non-structural influenza A viral protein NS1A as a bona fide target of the Small Ubiquitin-like MOdifier by the use of dicistronic expression constructs.

Sangita Pal, Juan M Rosas, Germán Rosas-Acosta

Abstract read
In one paragraph

Article in Journal of virological methods, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Viral Interplay with the Host Sumoylation System.Advances in experimental medicine and biology · 2017
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sangita PalDepartment of Biological Sciences, The University of Texas at El Paso, El Paso, TX, United States.
Juan M Rosas
Germán Rosas-Acosta

Funding

TOXICOLOGY PROJECTG12RR008124 · NCRR · UNIVERSITY OF TEXAS EL PASO · PI WALSH, ELIZABETH J · 1992 to 2011
$20.8M
The Sumoylation System as a Novel Target for Anti-Influenza TherapiesSC2AI081377 · NIAID · UNIVERSITY OF TEXAS EL PASO · PI ROSAS-ACOSTA, GERMAN · 2008 to 2010
$332k
NCRR NIH HHS 5G12RR008124NCRR NIH HHS G12 RR008124NIAID NIH HHS 1SC2AI081377-01NIAID NIH HHS SC2 AI081377
6 · The paper itself

Abstract

The cellular SUMOylation system affects the function of numerous viral proteins. Hence, the identification of novel viral targets for the Small Ubiquitin-like MOdifier (SUMO) is key to our understanding of virus-host interactions. The data obtained in this study demonstrate that the non-structural influenza A viral protein NS1A is an authentic SUMO target through the use of a dicistronic expression plasmid containing SUMO (the modifier) and Ubc9 (the SUMO-conjugating enzyme) separated by an Internal Ribosomal Entry Site (IRES). This dual expression plasmid produces a robust increase in cellular SUMOylation, therefore facilitating the characterization of cellular and viral SUMO targets. The identification of NS1A as a bona fide SUMO target suggests, for the first time, a role for SUMOylation during influenza virus infection.

Indexed as

Host-Pathogen InteractionsGenetic VectorsHumansOrthomyxoviridaePlasmidsSUMO-1 ProteinUbiquitinUbiquitinationUbiquitin-Conjugating EnzymesUbiquitin-Conjugating Enzyme UBC9Viral Nonstructural ProteinsINS1 protein, influenza virusSUMO-1 ProteinUbiquitinUbiquitin-Conjugating EnzymesUbiquitin-Conjugating Enzyme UBC9Viral Nonstructural Proteins

Identifiers

PMID19917317
PMCPMC2834654

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.